Moderna (MRNA) Jumps 2.2% in Premarket as Nasdaq-100 Entry Confirmed for October 9

Moderna (MRNA) stock rose 2.2% premarket on Nasdaq-100 inclusion news, even as Citi downgrades on valuation concerns after a 553% yearly surge.

The post Moderna (MRNA) Jumps 2.2% in Premarket as Nasdaq-100 Entry Confirmed for October 9 appeared first on Blockonomi.